Benign Brenner Tumor Mixed with Mucinous Cystadenoma of the Left Ovary: Case Report and Literature Review, 2023
Okbu Frezgi,Tiblets Tesfamichael,Khalid Farah,Hailemichael Gebremariam,Yasir Wahaballa,Berhe Tesfai
DOI: https://doi.org/10.2147/ijwh.s449117
2024-10-10
International Journal of Women s Health
Abstract:Okbu Frezgi, 1, 2 Tiblets Tesfamichael, 1 Khalid Hussein Farah, 1, 2 Hailemichael Gebremariam, 3 Yasir D Wahaballa, 4 Berhe Tesfai 1, 2 1 Obstetrics and Gynaecology Department, Orotta National Referral Maternity Hospital, Ministry of Health, Asmara, Eritrea; 2 Obstetrics and Gynaecology Department, Orotta College of Medicine and Health Sciences, Asmara, Eritrea; 3 Department of Obstetrics and Gynaecology, Dekemhare Hospital, Ministry of Health, Dekemhare, Eritrea; 4 Department Pathology, National Health Laboratory, Ministry of Health, Asmara, Eritrea Correspondence: Okbu Frezgi, Email Ovarian mucinous tumors mixed with Brenner tumors have rarely been reported. The coexistence of such epithelial tumors present histopathologic diagnostic difficulties. Here we report a 57-year-old postmenopausal woman who had experienced an abdominal distention and pain over a period of eight months. A physical examination revealed a grossly distended abdomen that reached the xiphoid process. A firm and mobile abdomino-pelvic mass with a smooth surface and a regular border was identified. Laboratory investigations showed a hemoglobin level of 13.54 g/dl and a serum cancer antigen 125 (CA125) of 97.3 U/mL. Trans abdominal ultrasonography revealed a massive complex mass originating from the left adnexa. A laparotomy was performed and a 10 kg left adnexal mass was removed intact. Histopathological analysis revealed mixed benign mucinous cystadenoma with a Brenner tumor of the left ovary. After surgery the patient showed marked clinical improvement, resumed her regular daily activities in three months and no recurrence has occurred during her long follow up. As the coexistence of these mixed tumors is not uncommon, a thorough pathologic evaluation is necessary and health professionals should be aware of the mixed occurrence of epithelial ovarian tumors. Keywords: co-existence, Brenner tumor, mucinous cystadenoma, ovarian tumor Ovarian tumors are the most lethal tumors, accounting for 30% of malignancies occurring in the female reproductive tract. 1 It is the leading cause of death from gynecologic malignancy due to its late presentation. 1–3 There are still no effective tools for general population screening and it is not cost effective to screen the whole population without risk stratification. 4 Ovarian cancers are subdivided into type I epithelial ovarian cancers, whcih are suggested to be relatively indolent and genetically stable tumors that typically arise from recognizable precursor lesions, such as endometriosis or borderline tumors with low malignant potential and type II epithelial ovarian cancers, which are proposed to be biologically aggressive tumors from their outset, with a propensity for metastasis from small volume primary lesions. 5 Based on origin, primary ovarian tumors are classified into epithelial, stromal and germ cell tumors. 1 Most tumors arise from the surface epithelium and are classified as serous, mucinous, endometrioid, clear cell, and Brenner tumors. 2,6,7 The World Health Organization (WHO) classifies ovarian neoplasms into 13 distinct categories. 8,9 A heterogeneous collection of neoplasms, such as mucinous and Brenner tumors, is not uncommon and have appeared in the pathology literature for over a century. 1,8–11 Mucinous epithelial ovarian tumors grow to enormous size, making the largest gynecological tumors and representing 10–15% of ovarian neoplasms. 1,12,13 Usually, at early stages, they are asymptomatic and the patient presents with abdominal swelling and pressure related symptoms. 2,9 Histopathologically, mucinous tumors are divided into benign, borderline, and malignant groups. Benign mucinous neoplasms include mucinous cystadenoma and mucinous adenofibroma and account for 80% of cases. 8 Brenner tumors are relatively rare epithelial neoplasms, accounting for 1.4% to 2.5% of all ovarian tumors. They usually affect postmenopausal women and are mostly benign (99%) in nature and in 30% of benign. 6,7,14 The mixed existence of epithelial ovarian tumors is common but the coexistence of mucinous and Brenner tumors is uncommon. 7,9,14 Minor foci of tumors other than the predominant ones can be ignored, but when substantial volumes (>10%) of several tumor types are present, the tumor is categorized as a mixed tumor. 8 Mucinous cystadenoma contains a component of a Brenner tumor, in 1.3–4% of ovarian mucinous neoplasms. 8,14 Interpreting the heterogeneous collection of neoplasms is the most difficult task for surgical pathologists. Due to rarity and disputed histogenesis, Brenner tumors are discussed by patholo -Abstract Truncated-
obstetrics & gynecology